GENE TRANSFER FOR ANGIOGENESIS IN CORONARY ARTERY DISEASE

Angiogenesis is a promising novel therapeutic strategy to provide new venues for blood flow in patients with severe ischemic heart and peripheral vascular disease, who are not candidates for standard revascularization strategies. We describe the underlying mechanisms involved in physiologic and ther...

Full description

Saved in:
Bibliographic Details
Published in:Annual review of medicine 2001-01, Vol.52 (1), p.485-502
Main Authors: Laham, Roger J, Simons, Michael, Sellke, Frank
Format: Article
Language:English
Subjects:
atherosclerosis
Biological and medical sciences
Cardiology. Vascular system
Coronary Disease - therapy
Coronary heart disease
Ethics, Medical
Forecasting
Gene Transfer Techniques - trends
Genetic Vectors - therapeutic use
Heart
Humans
ischemia
local delivery
Medical sciences
Neovascularization, Physiologic - genetics
no-option patients
Patient Advocacy
Research Design - standards
revascularization
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiogenesis is a promising novel therapeutic strategy to provide new venues for blood flow in patients with severe ischemic heart and peripheral vascular disease, who are not candidates for standard revascularization strategies. We describe the underlying mechanisms involved in physiologic and therapeutic angiogenesis, underscoring the relative importance of vasculogenesis, angiogenesis, and arteriogenesis. We then present the various gene transfer vectors including plasmid, viral, and cell-based vectors, and various delivery modalities. The available preclinical data are presented, followed by a description of preliminary clinical experience, with an emphasis on the preliminary nature of these results, which address safety and not efficacy. Finally, we discuss the promises and pitfalls of clinical angiogenesis and gene transfer studies, stressing the importance of proper design of clinical trials and adequate protection of research subjects.
ISSN:0066-4219
1545-326X
DOI:10.1146/annurev.med.52.1.485